HUE051541T2 - Eljárások citotoxikus benzodiazepin származékok elõállítására - Google Patents

Eljárások citotoxikus benzodiazepin származékok elõállítására

Info

Publication number
HUE051541T2
HUE051541T2 HUE16745598A HUE16745598A HUE051541T2 HU E051541 T2 HUE051541 T2 HU E051541T2 HU E16745598 A HUE16745598 A HU E16745598A HU E16745598 A HUE16745598 A HU E16745598A HU E051541 T2 HUE051541 T2 HU E051541T2
Authority
HU
Hungary
Prior art keywords
methods
benzodiazepine derivatives
cytotoxic benzodiazepine
preparing cytotoxic
preparing
Prior art date
Application number
HUE16745598A
Other languages
English (en)
Hungarian (hu)
Inventor
Baudouin Gerard
Manami Shizuka
Michael Miller
Richard Silva
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of HUE051541T2 publication Critical patent/HUE051541T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
HUE16745598A 2015-07-21 2016-07-21 Eljárások citotoxikus benzodiazepin származékok elõállítására HUE051541T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562195023P 2015-07-21 2015-07-21
US201662327973P 2016-04-26 2016-04-26

Publications (1)

Publication Number Publication Date
HUE051541T2 true HUE051541T2 (hu) 2021-03-01

Family

ID=56557925

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16745598A HUE051541T2 (hu) 2015-07-21 2016-07-21 Eljárások citotoxikus benzodiazepin származékok elõállítására

Country Status (23)

Country Link
US (11) US9890179B2 (enExample)
EP (7) EP4163284A1 (enExample)
JP (8) JP6787995B2 (enExample)
KR (5) KR102660070B1 (enExample)
CN (5) CN113087763A (enExample)
AU (7) AU2016297607A1 (enExample)
CA (4) CA2992082A1 (enExample)
CY (2) CY1122553T1 (enExample)
DK (2) DK3325483T3 (enExample)
ES (4) ES2820358T3 (enExample)
HK (1) HK1252322A1 (enExample)
HR (1) HRP20201479T1 (enExample)
HU (1) HUE051541T2 (enExample)
IL (10) IL294651B2 (enExample)
LT (2) LT3325482T (enExample)
PL (2) PL3325483T3 (enExample)
PT (2) PT3325483T (enExample)
RS (2) RS59806B1 (enExample)
RU (3) RU2727151C2 (enExample)
SG (2) SG10202106529XA (enExample)
SI (2) SI3325482T1 (enExample)
SM (2) SMT202000506T1 (enExample)
WO (3) WO2017015502A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL294651B2 (en) * 2015-07-21 2024-02-01 Immunogen Inc Methods for the preparation of cytotoxic benzodiazepine compounds
CN118098938A (zh) 2016-03-22 2024-05-28 Ev 集团 E·索尔纳有限责任公司 用于衬底的接合的装置和方法
WO2018075692A2 (en) 2016-10-19 2018-04-26 Invenra Inc. Antibody constructs
EP3559039A1 (en) 2016-12-22 2019-10-30 Università Degli Studi Magna Graecia Catanzaro A monoclonal antibody targeting a unique sialoglycosilated cancer-associated epitope of cd43
RU2762891C2 (ru) 2017-01-25 2021-12-23 Иммуноджен, Инк. Способы получения цитотоксических производных бензодиазепина
CN120795120A (zh) 2018-06-05 2025-10-17 伦敦大学国王学院 向胃肠系统递送酬载的btnl3/8导引构建体
EP3880656B1 (en) * 2018-11-12 2024-03-20 ImmunoGen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
EP3880681B1 (en) * 2018-11-12 2024-03-13 ImmunoGen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
KR20220010481A (ko) * 2019-03-29 2022-01-25 이뮤노젠 아이엔씨 비정상 세포 성장의 억제 또는 증식성 질환의 치료를 위한 세포독성 비스-벤조디아제핀 유도체 및 세포결합제와 이의 접합체
CN119486758A (zh) 2022-06-30 2025-02-18 东丽株式会社 癌的治疗和/或预防用药物组合物

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3763183A (en) 1972-07-10 1973-10-02 Sterling Drug Inc 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines
US3860600A (en) 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
US4678784A (en) 1984-04-11 1987-07-07 Mcneilab, Inc. Method for the treatment of LHRH diseases and conditions
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
GB9205051D0 (en) 1992-03-09 1992-04-22 Cancer Res Campaign Tech Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them
CA2076465C (en) 1992-03-25 2002-11-26 Ravi V. J. Chari Cell binding agent conjugates of analogues and derivatives of cc-1065
ES2244210T3 (es) 1998-08-27 2005-12-01 Spirogen Limited Pirrolobenzodiazepinas.
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
DE60032633T2 (de) 1999-11-24 2007-10-04 Immunogen Inc., Cambridge Zytotoxische mittel, die taxane enthalten und ihre therapeutische anwendung
US6548042B2 (en) * 2000-08-07 2003-04-15 Arstad Erik Bis-phosphonate compounds
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6756397B2 (en) 2002-04-05 2004-06-29 Immunogen, Inc. Prodrugs of CC-1065 analogs
WO2004013093A2 (en) 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
ES2361739T3 (es) 2002-08-16 2011-06-21 Immunogen, Inc. Reticulantes con elevada reactividad y solubilidad y su uso en la preparación de conjugados para el suministro dirigido de fármacos de molécula pequeña.
RU2338747C2 (ru) 2003-03-31 2008-11-20 Каунсил Оф Сайентифик Энд Индастриал Рисерч ДИМЕРЫ ПИРРОЛО [2, 1-c][1, 4] БЕНЗОДИАЗЕПИНА В КАЧЕСТВЕ ПРОТИВООПУХОЛЕВЫХ СРЕДСТВ И СПОСОБ ИХ ПОЛУЧЕНИЯ
AU2003215810B2 (en) 2003-03-31 2009-06-18 Council Of Scientific And Industrial Research Pyrrolo((2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
US6884799B2 (en) 2003-03-31 2005-04-26 Council Of Scientific And Industrial Research Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof
RU2314309C2 (ru) 2003-03-31 2008-01-10 Каунсил Оф Сайентифик Энд Индастриал Рисерч Пирроло [2.1-c][1.4] бензодиазепины, способ их получения и фармацевтическая композиция на их основе
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
CA2543318C (en) 2003-10-22 2013-01-08 B. Rao Vishnuvajjala Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
WO2005063759A1 (en) 2003-12-31 2005-07-14 Council Of Scientific And Industrial Research PROCESS FOR PREPARING PYRROLO[2, 1-c] [1, 4] BENZODIAZEPINE HYBRIDS
GB0404578D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
PT2270010E (pt) * 2004-03-01 2012-03-12 Spirogen Ltd Derivados de 11-hidroxi-5h-pirrolo[2,1-c][1,4]benzodiazepin- 5-ona como intermediários chave para a preparação de pirrolobenzodiazepinas substituídas em c2
GB0410725D0 (en) 2004-05-13 2004-06-16 Spirogen Ltd Pyrrolobenzodiazepine therapeutic agents
GB0412492D0 (en) * 2004-06-04 2004-07-07 Sterix Ltd Compound
GB0508084D0 (en) * 2005-04-21 2005-06-01 Spirogen Ltd Pyrrolobenzodiazepines
US7612062B2 (en) 2005-04-21 2009-11-03 Spirogen Limited Pyrrolobenzodiazepines
ATE427949T1 (de) 2005-10-05 2009-04-15 Spirogen Ltd 4-a4-(5-oxo-2,3,5,11a-tetrahydro-5h-pyrrolo a2, 1-cua1,4ubenzodiazepin-8-yloxy)-butyrylaminou-1 - pyrrol-2-carbonsaurealkylesterderivate und verwandte verbindung zur behandlung einer proliferativen erkrankung
ATE475660T1 (de) * 2005-12-21 2010-08-15 Abbott Lab Antivirale verbindungen
ATE527262T1 (de) 2006-01-25 2011-10-15 Sanofi Sa Neue tomaymycin derivate enhaltende zytotoxische mittel
DE112007000079B4 (de) 2006-02-13 2015-08-13 Council Of Scientific & Industrial Research Neuartige Bis-Pyrrolo[2,1-c][1,4]benzodiazepin-anthrachinon Konjugate und ein Verfahren zu deren Herstellung
PT2032606E (pt) 2006-05-30 2014-02-05 Genentech Inc Anticorpos e imunoconjugados e respetivas utilizações
SI2019104T1 (sl) 2007-07-19 2013-12-31 Sanofi Citotoksična sredstva, ki obsegajo nove tomaimicinske derivate, in njihova terapevtska uporaba
ATE543826T1 (de) 2007-08-01 2012-02-15 Council Scient Ind Res Als selektive antitumormittel geeignete pyrroloä2,1-cüä1,4übenzodiazepinglycosid-prodru s
UA108598C2 (xx) 2008-04-30 2015-05-25 Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
KR101892411B1 (ko) 2008-04-30 2018-08-27 이뮤노젠 아이엔씨 가교제 및 그 용도
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
GB0822260D0 (en) * 2008-12-05 2009-01-14 Merten Christoph Assay
EP2383263B1 (en) * 2008-12-30 2014-04-16 Industry-academic Cooperation Foundation, Chosun University Novel thiazolidinedione derivative and use thereof
IL271761B (en) 2009-02-05 2022-09-01 Immunogen Inc (12as)-8-methoxy-9-benzyloxy-11,12,12a,13-tetrahydro-6h-indolo[2,1-c][1,4]benzodiazepin-6-one, 4-benzyloxy-5-methoxy-2-nitrobenzoic acid and processes for preparing the same
KR20120080611A (ko) 2009-10-06 2012-07-17 이뮤노젠 아이엔씨 효능 있는 접합체 및 친수성 링커
US8314250B2 (en) * 2009-11-24 2012-11-20 Hoffmann-La Roche Inc. Sultam derivatives
WO2011071078A1 (ja) * 2009-12-08 2011-06-16 国立大学法人岐阜大学 芳香族化合物、並びに、それを用いたオリゴヌクレオチド誘導体合成用修飾担体、オリゴヌクレオチド誘導体及びオリゴヌクレオチド構築物
US8962279B2 (en) * 2009-12-30 2015-02-24 Intel Corporation Solid-phase chelators and electronic biosensors
TR201903027T4 (tr) * 2010-02-11 2019-03-21 Celgene Corp Arilmetoksi izoindolin türevleri ve bunları içeren kompozisyonlar ve bunları kullanma yöntemleri.
EP3196212B1 (en) 2010-02-24 2020-06-03 ImmunoGen, Inc. Immunoconjugates comprising a folate receptor 1 antibody
MX2012011900A (es) 2010-04-15 2013-03-21 Seattle Genetics Inc Conjugados de pirrolobenzodiazepina diana.
EP2558475A1 (en) 2010-04-15 2013-02-20 Spirogen Sàrl Pyrrolobenzodiazepines used to treat proliferative diseases
NZ602241A (en) 2010-04-15 2015-03-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
CN113896731A (zh) * 2011-02-15 2022-01-07 伊缪诺金公司 细胞毒性苯并二氮杂䓬衍生物
CN102234253B (zh) * 2011-06-02 2013-07-03 重庆莱美药业股份有限公司 一种制备非布索坦中间体的方法
EP2887965A1 (en) 2012-08-22 2015-07-01 ImmunoGen, Inc. Cytotoxic benzodiazepine derivatives
WO2015051045A2 (en) 2013-10-04 2015-04-09 Novartis Ag 3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE
CN104628772A (zh) * 2013-11-07 2015-05-20 四川恒康发展有限责任公司 一种抗肿瘤前药及其激活剂、组合物和应用
CN103664896B (zh) * 2013-11-25 2016-03-02 济南精合医药科技有限公司 一种抗肿瘤分子靶向药物克里唑替尼的合成工艺方法
PL3189056T3 (pl) 2014-09-03 2020-11-02 Immunogen, Inc. Cytotoksyczne pochodne benzodiazepinowe
US9381256B2 (en) 2014-09-03 2016-07-05 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
TW201609152A (zh) * 2014-09-03 2016-03-16 免疫原公司 包含細胞結合劑及細胞毒性劑之偶聯物
IL294651B2 (en) * 2015-07-21 2024-02-01 Immunogen Inc Methods for the preparation of cytotoxic benzodiazepine compounds
PT3380525T (pt) * 2015-11-25 2024-02-05 Immunogen Inc Formulações farmacêuticas e métodos que as utilizam

Also Published As

Publication number Publication date
IL256860B (en) 2020-08-31
PT3325483T (pt) 2020-01-15
RU2018105609A3 (enExample) 2020-04-30
HRP20201479T1 (hr) 2020-12-11
JP2018524387A (ja) 2018-08-30
JP2023162264A (ja) 2023-11-08
US10899775B2 (en) 2021-01-26
ES2959741T3 (es) 2024-02-28
RU2018105756A (ru) 2019-08-21
KR102660070B1 (ko) 2024-04-24
EP3325483A1 (en) 2018-05-30
SI3325482T1 (sl) 2020-11-30
KR102659706B1 (ko) 2024-04-23
PL3325482T3 (pl) 2021-01-11
US10787463B2 (en) 2020-09-29
SG10202009354SA (en) 2020-11-27
EP3325482B1 (en) 2020-06-24
EP3325485B1 (en) 2020-04-08
AU2023201339A1 (en) 2023-04-06
EP4163284A1 (en) 2023-04-12
RU2018105752A3 (enExample) 2019-12-30
WO2017015502A8 (en) 2017-03-02
RU2018105609A (ru) 2019-08-26
IL276630A (en) 2020-09-30
EP3778602B1 (en) 2023-07-12
US20170050986A1 (en) 2017-02-23
EP3325485A1 (en) 2018-05-30
CY1123390T1 (el) 2022-03-24
ES2820358T3 (es) 2021-04-20
CN108026103A (zh) 2018-05-11
US20180201626A1 (en) 2018-07-19
AU2016297087A1 (en) 2018-02-08
IL256861A (en) 2018-03-29
RS60840B1 (sr) 2020-10-30
IL283355B (en) 2022-08-01
CA2992082A1 (en) 2017-01-26
JP2018526340A (ja) 2018-09-13
IL294651B1 (en) 2023-10-01
US10392407B2 (en) 2019-08-27
KR20180038460A (ko) 2018-04-16
CA3227588A1 (en) 2017-01-26
EP3778602A1 (en) 2021-02-17
CN108055844A (zh) 2018-05-18
AU2016297608B2 (en) 2021-02-18
WO2017015495A1 (en) 2017-01-26
IL283355A (en) 2021-07-29
CN113004288A (zh) 2021-06-22
IL256854A (en) 2018-03-29
JP2021100959A (ja) 2021-07-08
CN108026103B (zh) 2021-04-16
JP2018522018A (ja) 2018-08-09
AU2016297087B2 (en) 2021-02-18
HK1252323A1 (en) 2019-05-24
US9890179B2 (en) 2018-02-13
AU2023202221A1 (en) 2023-05-04
RU2018105756A3 (enExample) 2019-12-23
LT3325482T (lt) 2020-11-25
KR20180026741A (ko) 2018-03-13
IL294651B2 (en) 2024-02-01
ES2764548T3 (es) 2020-06-03
HK1252321A1 (en) 2019-05-24
WO2017015502A1 (en) 2017-01-26
JP6995178B2 (ja) 2022-02-21
US20190389883A1 (en) 2019-12-26
SMT202000506T1 (it) 2020-11-10
DK3325483T3 (da) 2020-01-20
US20190112320A1 (en) 2019-04-18
RU2018105752A (ru) 2019-08-21
IL276631B (en) 2021-10-31
US20230257400A1 (en) 2023-08-17
EP3325482A1 (en) 2018-05-30
KR20240055903A (ko) 2024-04-29
CN108290895A (zh) 2018-07-17
RS59806B1 (sr) 2020-02-28
US20190010169A1 (en) 2019-01-10
CN113087763A (zh) 2021-07-09
KR20180038461A (ko) 2018-04-16
JP7337114B2 (ja) 2023-09-01
IL286788B2 (en) 2024-01-01
CY1122553T1 (el) 2021-01-27
IL256860A (en) 2018-03-29
IL305279A (en) 2023-10-01
AU2021202403B2 (en) 2022-12-08
US9873708B2 (en) 2018-01-23
CA2991305A1 (en) 2017-01-26
AU2021203148B2 (en) 2023-01-12
EP3653628A1 (en) 2020-05-20
IL256861B (en) 2020-08-31
US10081640B2 (en) 2018-09-25
JP2023166434A (ja) 2023-11-21
KR20240055894A (ko) 2024-04-29
IL276631A (en) 2020-09-30
US11420982B2 (en) 2022-08-23
PT3325482T (pt) 2020-09-24
JP6787995B2 (ja) 2020-11-18
DK3325482T3 (da) 2020-09-28
EP3325483B1 (en) 2019-10-02
US20210171547A1 (en) 2021-06-10
JP7334228B2 (ja) 2023-08-28
JP2022046542A (ja) 2022-03-23
SI3325483T1 (sl) 2020-03-31
HK1252322A1 (zh) 2019-05-24
AU2021202403A1 (en) 2021-05-20
US20170050985A1 (en) 2017-02-23
CA2991326A1 (en) 2017-01-26
IL305989A (en) 2023-11-01
US20210171546A1 (en) 2021-06-10
AU2016297608A1 (en) 2018-02-08
PL3325483T3 (pl) 2020-05-18
AU2021203148A1 (en) 2021-06-10
WO2017015496A1 (en) 2017-01-26
IL276630B (en) 2021-06-30
LT3325483T (lt) 2020-01-27
JP6858745B2 (ja) 2021-04-14
CA2991305C (en) 2024-03-12
EP4286387A2 (en) 2023-12-06
IL286788A (en) 2021-10-31
US20200017526A1 (en) 2020-01-16
JP2021035958A (ja) 2021-03-04
US20170051011A1 (en) 2017-02-23
AU2016297607A1 (en) 2018-02-08
IL286788B1 (en) 2023-09-01
RU2727151C2 (ru) 2020-07-21
SMT202000004T1 (it) 2020-03-13
SG10202106529XA (en) 2021-07-29
RU2746322C2 (ru) 2021-04-12
EP4286387A3 (en) 2024-02-21
IL294651A (en) 2022-09-01
CN108290895B (zh) 2021-03-19
US10370389B2 (en) 2019-08-06
ES2933376T3 (es) 2023-02-06
EP3653628B1 (en) 2022-09-14

Similar Documents

Publication Publication Date Title
IL291598A (en) History of benzodiazepine cytotoxicity
IL286788A (en) Methods for the preparation of cytotoxic benzodiazepine compounds
SG11201706729SA (en) Derivatives of sobetirome
HUE056357T2 (hu) Szobetirom származékok
IL287405A (en) Methods for preparing cytotoxic benzodiazepine derivatives
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
IL283045A (en) Methods for preparing cytotoxic benzodiazepine derivatives
IL283047A (en) Methods for preparing cytotoxic benzodiazepine derivatives
GB201414116D0 (en) Benzodiazepine derivatives
GB201513979D0 (en) Synthesis of benzodiazepine derivatives
HUP1400545A2 (hu) Eljárás benzazepin származékok elõállítására
HK1236934A1 (zh) 细胞毒性苯并二氮呯衍生物